About Dr. Shishir Seth
- Dr. Shishir Seth is a well-known Haematologist practicing successfully for more than 25+ years.
- He is skilled in treating patients suffering from Acute Leukaemia (AML/ ALL), Lymphoma, Multiple Myeloma, CML, CLL, Chronic Myeloproliferative Neoplasm, Myelodysplastic syndrome as well as anemia, Thalassemia, Bleeding and clotting disorders.
- In his career, he has performed 150 Hematopoietic BMT, 40% of which was allogenic including Haplo-identical and antigen mismatch transplantations.
- He has also performed 300 induction therapies for acute leukemia.
- Dr. Shishir is the Life Member of the Indian Society of Haematology and Transfusion Medicine and a member of American Society of Clinical Oncology and American Society of Haematology.
- He takes a keen interest in research and has several publications to his credit in National and International journals.
Location
New Delhi, IndiaSpecial Interest
Haemato-Oncology Leukaemia Acute Leukaemia (AML/ ALL) Lymphoma Multiple Myeloma Bone Marrow Transplant CML CLL Chronic Myeloproliferative Neoplasm Myelodysplastic syndrome Anemia Thalassemia Bleeding and clotting disorders Induction therapies for acute leukemia
List Of Treatments
- Aplastic Anemia
- Myelodysplastic Syndrome (MDS) Treatment - Preleukemia
- Allogeneic Bone Marrow Transplant
- Thalassemia Treatment
- Bone Marrow Transplant
- Autologous Bone Marrow Transplant
- Sickle Cell Anemia
Work Experience of Dr. Shishir Seth
Dr. Shishir Seth's
- MBBS, 1999, Chaudhary Charan Singh University, Meerut
- MD, 2005, Pathology in University of Mumbai, Mumbai
- DM, 2009, Clinical Haematology, Maharashtra university of Health Science, Nasik
- Fellowship, Leukaemia & Blood & Marrow Transplant; Vancouver General Hospital, University of British Columbia, British Columbia Cancer Agency. Vancouver – BC – Canada
- Associated with research and has several publications to his credit in noted national and international journals. These are: An unusual presentation of paediatric acute lymphoblastic leukaemia. Indian J Hematol Blood Transfuse, 2008; :24(2) 59-62
- “Lymph node and Tuberculosis: Clinical, Pathological and Microbiological Correlation.” In CYTOCON-2003 at Pune, India
- “Spectrum of small intestinal lymphoma in western India” in International conference on emerging trends in haematology and Immuno-hematology at Mumbai, India
- “Chronic Myeloid Leukaemia: Demographic and clinical profile from a tertiary center in western India” in Leukaemias: molecular insights to treatment paradigms at Mumbai
- Hematopoietic Cell Transplantation in Lymphoma: Why & When; Evidence Based Review. Cancer News, Dec 2011; 5(5) 10-12
- Acute Myeloid Leukaemia- An Update, RGCI Newsletter-External- Mar 2012; 16(3) 2-3
- He was the Principal investigator for 2010DRL001: An investigator initiated observational study to evaluate the response rate and toxicity (safety) of the combination of bendamustine and Rituximab (BR) in fresh adult chronic lymphocytic leukaemia patients and
- Principal Investigator for IVPL_RT_01: A study of Rituximab in patients with Non Hodgkin’s Lymphoma a type of cancer.
(Get Free opinion, Quote, Medical Visa Invitation and Assistance at every step of your treatment.)
Doctor Similar to Dr. Shishir Seth in New Delhi
Hematologist
Senior Consultant
DCH,DNB,Fellowship,MBBS
New Delhi, India
23 years of experience
Hematologist
Consultant
DNB,Fellowship,MBBS,MD
New Delhi, India
13 years of experience
Hematologist
Senior Consultant
MBBS,MD
New Delhi, India
23 years of experience
Hematologist
Senior Consultant
DNB,MBBS,MD
New Delhi, India
27 years of experience
Fortis Flt. Lt. Rajan Dhall Hospital, Vasant Kunj, New Delhi